BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan X, Cheng X, Zhou L, He X, Zheng W, Chen H. Dexmedetomidine alleviates lipopolysaccharide-induced lung injury in Wistar rats. Oncotarget 2017;8:44410-7. [PMID: 28574842 DOI: 10.18632/oncotarget.17899] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao W, Jia L, Yang HJ, Xue X, Xu WX, Cai JQ, Guo RJ, Cao CC. Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system. Biomed Pharmacother 2018;103:1362-8. [PMID: 29864919 DOI: 10.1016/j.biopha.2018.04.150] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zeng W, Zhang C, Long Q, Li Y. Dexmedetomidine Alleviates LPS-Induced Neuronal Dysfunction by Modulating the AKT/GSK-3β/CRMP-2 Pathway in Hippocampal Neurons. Neuropsychiatr Dis Treat 2021;17:671-80. [PMID: 33727816 DOI: 10.2147/NDT.S297365] [Reference Citation Analysis]
3 Li J, Dou X, Li D, He M, Han M, Zhang H. Dexmedetomidine Ameliorates Post-CPB Lung Injury in Rats by Activating the PI3K/Akt Pathway. J Invest Surg 2020;33:576-83. [PMID: 30913929 DOI: 10.1080/08941939.2018.1529839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 He GR, Lin XK, Wang YB, Chen CD. Dexmedetomidine impairs P‑glycoprotein‑mediated efflux function in L02 cells via the adenosine 5'‑monophosphate‑activated protein kinase/nuclear factor‑κB pathway. Mol Med Rep 2018;17:5049-56. [PMID: 29393492 DOI: 10.3892/mmr.2018.8549] [Reference Citation Analysis]
5 Kang L, Yayi H, Fang Z, Bo Z, Zhongyuan X. Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain. Acta Cir Bras 2019;34:e201901105. [PMID: 31859818 DOI: 10.1590/s0102-865020190110000005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Chen Y, Bian W, Xu B. Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion. Mol Med Rep 2020;21:1233-41. [PMID: 32016469 DOI: 10.3892/mmr.2020.10942] [Reference Citation Analysis]
7 Kong Q, Wu X, Qiu Z, Huang Q, Xia Z, Song X. Protective Effect of Dexmedetomidine on Acute Lung Injury via the Upregulation of Tumour Necrosis Factor-α-Induced Protein-8-like 2 in Septic Mice. Inflammation 2020;43:833-46. [PMID: 31927655 DOI: 10.1007/s10753-019-01169-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
8 Wang X, Zhang B, Li G, Zhao H, Tian X, Yu J, Yin Y, Meng C, Hayashi Y. Dexmedetomidine Alleviates Lung Oxidative Stress Injury Induced by Ischemia-Reperfusion in Diabetic Rats via the Nrf2-Sulfiredoxin1 Pathway. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/5584733] [Reference Citation Analysis]